
Unigrains, Sofiproteol back Caussade Semences
French GPs Unigrains and Sofiproteol have invested in France-based Caussade Semences Group, a seed production group.
Unigrains and Sofiprotéol have invested in quasi-equity (convertible bonds) in the context of a fundraising by Caussade Semences. No equity stake was directly acquired in this debt financing, Unquote understands.
The proceeds of the fundraising will be used to foster Caussade Semences' development in France and abroad.
Unigrains has a track record in the seeds sector, having supported companies like Limagrains, Euralis Semences and RAGT Seeds.
Both GPs have a focus in agri-business. Italy-based Sinfo One and France-based Roger Descours are among Unigrains' most recent acquisitions, according to Unquote Data.
Sofiproteol is the finance and development company of Avril, an industrial and finance actor of the French oilseeds and proteins sectors. The group recently exited from Sopral, selling it to Parquest in Q4 last year.
Founded in 1958, Caussade Semences is a multi-species seed group. The company selects, produces and markets field seeds including corn, sunflower, rapeseed, straw cereals, forage crops, protein crops, soybeans and plant cover crops.
Based in Caussade, the company generates revenue of €145m and has 630 employees. It operates 11 research sites and five production facilities and has a presence in 35 countries.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater